Fluorine in PDB 3v5q: Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Enzymatic activity of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
All present enzymatic activity of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models:
2.7.10.1;
Protein crystallography data
The structure of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models, PDB code: 3v5q
was solved by
A.Kreusch,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
40.95 /
2.20
|
Space group
|
P 32
|
Cell size a, b, c (Å), α, β, γ (°)
|
65.580,
65.580,
177.252,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
21.2 /
26.4
|
Other elements in 3v5q:
The structure of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
(pdb code 3v5q). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models, PDB code: 3v5q:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 3v5q
Go back to
Fluorine Binding Sites List in 3v5q
Fluorine binding site 1 out
of 6 in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F902
b:39.0
occ:1.00
|
F1
|
A:0F4902
|
0.0
|
39.0
|
1.0
|
C2
|
A:0F4902
|
1.3
|
36.0
|
1.0
|
F3
|
A:0F4902
|
2.1
|
42.9
|
1.0
|
F4
|
A:0F4902
|
2.1
|
38.0
|
1.0
|
C5
|
A:0F4902
|
2.3
|
35.9
|
1.0
|
C6
|
A:0F4902
|
2.8
|
35.2
|
1.0
|
C38
|
A:0F4902
|
3.6
|
36.3
|
1.0
|
CD2
|
A:LEU670
|
3.7
|
32.5
|
1.0
|
CD2
|
A:LEU595
|
3.7
|
40.3
|
1.0
|
CG2
|
A:ILE600
|
3.9
|
35.4
|
1.0
|
C7
|
A:0F4902
|
4.1
|
39.1
|
1.0
|
CD1
|
A:LEU670
|
4.3
|
27.3
|
1.0
|
CD1
|
A:ILE600
|
4.3
|
30.2
|
1.0
|
CE2
|
A:PHE675
|
4.3
|
34.0
|
1.0
|
CG
|
A:LEU595
|
4.4
|
41.8
|
1.0
|
CG
|
A:LEU670
|
4.5
|
33.5
|
1.0
|
CD2
|
A:HIS677
|
4.6
|
32.7
|
1.0
|
O
|
A:ILE695
|
4.7
|
31.8
|
1.0
|
C9
|
A:0F4902
|
4.7
|
42.2
|
1.0
|
CD2
|
A:PHE675
|
4.8
|
32.8
|
1.0
|
CZ
|
A:PHE675
|
4.8
|
33.8
|
1.0
|
CG2
|
A:ILE695
|
4.9
|
28.8
|
1.0
|
CG1
|
A:ILE600
|
4.9
|
33.4
|
1.0
|
CD2
|
A:LEU592
|
4.9
|
33.4
|
1.0
|
C8
|
A:0F4902
|
4.9
|
34.4
|
1.0
|
CB
|
A:ILE600
|
5.0
|
34.3
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 3v5q
Go back to
Fluorine Binding Sites List in 3v5q
Fluorine binding site 2 out
of 6 in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F902
b:42.9
occ:1.00
|
F3
|
A:0F4902
|
0.0
|
42.9
|
1.0
|
C2
|
A:0F4902
|
1.3
|
36.0
|
1.0
|
F1
|
A:0F4902
|
2.1
|
39.0
|
1.0
|
F4
|
A:0F4902
|
2.2
|
38.0
|
1.0
|
C5
|
A:0F4902
|
2.3
|
35.9
|
1.0
|
C38
|
A:0F4902
|
2.7
|
36.3
|
1.0
|
O
|
A:ILE695
|
3.2
|
31.8
|
1.0
|
CG2
|
A:ILE600
|
3.3
|
35.4
|
1.0
|
CA
|
A:GLY696
|
3.3
|
31.0
|
1.0
|
C6
|
A:0F4902
|
3.5
|
35.2
|
1.0
|
C
|
A:GLY696
|
3.8
|
36.9
|
1.0
|
C
|
A:ILE695
|
3.8
|
31.6
|
1.0
|
N
|
A:GLY696
|
4.0
|
26.4
|
1.0
|
C9
|
A:0F4902
|
4.1
|
42.2
|
1.0
|
N
|
A:ASP697
|
4.2
|
38.2
|
1.0
|
O
|
A:GLY696
|
4.3
|
35.6
|
1.0
|
O12
|
A:0F4902
|
4.4
|
36.7
|
1.0
|
CD2
|
A:LEU592
|
4.5
|
33.4
|
1.0
|
CB
|
A:ILE600
|
4.6
|
34.3
|
1.0
|
CD1
|
A:ILE600
|
4.7
|
30.2
|
1.0
|
C7
|
A:0F4902
|
4.7
|
39.1
|
1.0
|
N
|
A:VAL601
|
4.7
|
30.6
|
1.0
|
CG2
|
A:ILE695
|
4.7
|
28.8
|
1.0
|
C8
|
A:0F4902
|
4.9
|
34.4
|
1.0
|
CA
|
A:ILE600
|
4.9
|
31.2
|
1.0
|
CB
|
A:ILE695
|
5.0
|
29.6
|
1.0
|
N10
|
A:0F4902
|
5.0
|
43.5
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 3v5q
Go back to
Fluorine Binding Sites List in 3v5q
Fluorine binding site 3 out
of 6 in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F902
b:38.0
occ:1.00
|
F4
|
A:0F4902
|
0.0
|
38.0
|
1.0
|
C2
|
A:0F4902
|
1.3
|
36.0
|
1.0
|
F1
|
A:0F4902
|
2.1
|
39.0
|
1.0
|
F3
|
A:0F4902
|
2.2
|
42.9
|
1.0
|
C5
|
A:0F4902
|
2.3
|
35.9
|
1.0
|
C38
|
A:0F4902
|
3.1
|
36.3
|
1.0
|
O
|
A:GLY696
|
3.1
|
35.6
|
1.0
|
C
|
A:GLY696
|
3.2
|
36.9
|
1.0
|
C6
|
A:0F4902
|
3.2
|
35.2
|
1.0
|
CD2
|
A:HIS677
|
3.2
|
32.7
|
1.0
|
NE2
|
A:HIS677
|
3.3
|
33.5
|
1.0
|
CA
|
A:GLY696
|
3.5
|
31.0
|
1.0
|
CG2
|
A:ILE695
|
3.6
|
28.8
|
1.0
|
N
|
A:ASP697
|
3.7
|
38.2
|
1.0
|
CB
|
A:ASP697
|
3.9
|
34.6
|
1.0
|
N
|
A:GLY696
|
3.9
|
26.4
|
1.0
|
O
|
A:ILE695
|
4.1
|
31.8
|
1.0
|
C
|
A:ILE695
|
4.1
|
31.6
|
1.0
|
CA
|
A:ASP697
|
4.3
|
39.5
|
1.0
|
C9
|
A:0F4902
|
4.4
|
42.2
|
1.0
|
C7
|
A:0F4902
|
4.4
|
39.1
|
1.0
|
CG
|
A:HIS677
|
4.5
|
30.6
|
1.0
|
CE1
|
A:HIS677
|
4.6
|
35.0
|
1.0
|
CB
|
A:ILE695
|
4.6
|
29.6
|
1.0
|
CD1
|
A:LEU670
|
4.7
|
27.3
|
1.0
|
CE2
|
A:PHE675
|
4.9
|
34.0
|
1.0
|
C8
|
A:0F4902
|
4.9
|
34.4
|
1.0
|
O12
|
A:0F4902
|
5.0
|
36.7
|
1.0
|
CG
|
A:ASP697
|
5.0
|
39.4
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 3v5q
Go back to
Fluorine Binding Sites List in 3v5q
Fluorine binding site 4 out
of 6 in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F901
b:37.6
occ:1.00
|
F1
|
B:0F4901
|
0.0
|
37.6
|
1.0
|
C2
|
B:0F4901
|
1.3
|
35.9
|
1.0
|
F3
|
B:0F4901
|
2.1
|
44.5
|
1.0
|
F4
|
B:0F4901
|
2.2
|
40.0
|
1.0
|
C5
|
B:0F4901
|
2.2
|
35.3
|
1.0
|
C6
|
B:0F4901
|
2.6
|
35.5
|
1.0
|
CD2
|
B:LEU595
|
3.2
|
39.8
|
1.0
|
C38
|
B:0F4901
|
3.5
|
33.8
|
1.0
|
CD2
|
B:LEU670
|
3.6
|
27.5
|
1.0
|
C7
|
B:0F4901
|
3.9
|
36.7
|
1.0
|
CG2
|
B:ILE600
|
3.9
|
32.5
|
1.0
|
CG
|
B:LEU595
|
4.1
|
47.2
|
1.0
|
CD1
|
B:ILE600
|
4.3
|
32.5
|
1.0
|
CD1
|
B:LEU670
|
4.4
|
26.3
|
1.0
|
CE1
|
B:PHE675
|
4.5
|
34.4
|
1.0
|
CG
|
B:LEU670
|
4.6
|
32.1
|
1.0
|
C9
|
B:0F4901
|
4.6
|
37.4
|
1.0
|
CD2
|
B:HIS677
|
4.7
|
29.3
|
1.0
|
C8
|
B:0F4901
|
4.7
|
36.7
|
1.0
|
CD2
|
B:LEU592
|
4.8
|
34.9
|
1.0
|
O
|
B:ILE695
|
4.8
|
27.5
|
1.0
|
CD1
|
B:PHE675
|
4.8
|
31.9
|
1.0
|
CZ
|
B:PHE675
|
4.8
|
33.2
|
1.0
|
CG1
|
B:ILE600
|
4.8
|
34.6
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 3v5q
Go back to
Fluorine Binding Sites List in 3v5q
Fluorine binding site 5 out
of 6 in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F901
b:44.5
occ:1.00
|
F3
|
B:0F4901
|
0.0
|
44.5
|
1.0
|
C2
|
B:0F4901
|
1.3
|
35.9
|
1.0
|
F1
|
B:0F4901
|
2.1
|
37.6
|
1.0
|
F4
|
B:0F4901
|
2.2
|
40.0
|
1.0
|
C5
|
B:0F4901
|
2.3
|
35.3
|
1.0
|
C38
|
B:0F4901
|
2.8
|
33.8
|
1.0
|
CG2
|
B:ILE600
|
3.1
|
32.5
|
1.0
|
O
|
B:ILE695
|
3.2
|
27.5
|
1.0
|
CA
|
B:GLY696
|
3.5
|
32.2
|
1.0
|
C6
|
B:0F4901
|
3.5
|
35.5
|
1.0
|
C
|
B:ILE695
|
3.9
|
35.5
|
1.0
|
C
|
B:GLY696
|
4.0
|
37.9
|
1.0
|
N
|
B:GLY696
|
4.1
|
29.8
|
1.0
|
C9
|
B:0F4901
|
4.2
|
37.4
|
1.0
|
N
|
B:ASP697
|
4.4
|
36.2
|
1.0
|
CD1
|
B:ILE600
|
4.4
|
32.5
|
1.0
|
CB
|
B:ILE600
|
4.4
|
32.6
|
1.0
|
CD2
|
B:LEU592
|
4.5
|
34.9
|
1.0
|
O12
|
B:0F4901
|
4.5
|
36.4
|
1.0
|
O
|
B:GLY696
|
4.7
|
40.1
|
1.0
|
C7
|
B:0F4901
|
4.7
|
36.7
|
1.0
|
CG2
|
B:ILE695
|
4.7
|
30.6
|
1.0
|
N
|
B:VAL601
|
4.7
|
29.0
|
1.0
|
CD2
|
B:LEU595
|
4.8
|
39.8
|
1.0
|
CG1
|
B:ILE600
|
4.9
|
34.6
|
1.0
|
CA
|
B:ILE600
|
4.9
|
31.5
|
1.0
|
C8
|
B:0F4901
|
4.9
|
36.7
|
1.0
|
CB
|
B:ILE695
|
5.0
|
30.9
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 3v5q
Go back to
Fluorine Binding Sites List in 3v5q
Fluorine binding site 6 out
of 6 in the Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Discovery of A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F901
b:40.0
occ:1.00
|
F4
|
B:0F4901
|
0.0
|
40.0
|
1.0
|
C2
|
B:0F4901
|
1.3
|
35.9
|
1.0
|
F3
|
B:0F4901
|
2.2
|
44.5
|
1.0
|
F1
|
B:0F4901
|
2.2
|
37.6
|
1.0
|
C5
|
B:0F4901
|
2.3
|
35.3
|
1.0
|
C6
|
B:0F4901
|
3.1
|
35.5
|
1.0
|
C38
|
B:0F4901
|
3.1
|
33.8
|
1.0
|
C
|
B:GLY696
|
3.2
|
37.9
|
1.0
|
O
|
B:GLY696
|
3.3
|
40.1
|
1.0
|
CD2
|
B:HIS677
|
3.4
|
29.3
|
1.0
|
CA
|
B:GLY696
|
3.4
|
32.2
|
1.0
|
NE2
|
B:HIS677
|
3.5
|
33.3
|
1.0
|
CG2
|
B:ILE695
|
3.6
|
30.6
|
1.0
|
N
|
B:ASP697
|
3.7
|
36.2
|
1.0
|
N
|
B:GLY696
|
3.9
|
29.8
|
1.0
|
O
|
B:ILE695
|
4.0
|
27.5
|
1.0
|
C
|
B:ILE695
|
4.1
|
35.5
|
1.0
|
CB
|
B:ASP697
|
4.1
|
33.4
|
1.0
|
C7
|
B:0F4901
|
4.3
|
36.7
|
1.0
|
C9
|
B:0F4901
|
4.3
|
37.4
|
1.0
|
CA
|
B:ASP697
|
4.4
|
38.7
|
1.0
|
CB
|
B:ILE695
|
4.5
|
30.9
|
1.0
|
CG
|
B:HIS677
|
4.7
|
30.7
|
1.0
|
CE1
|
B:HIS677
|
4.7
|
35.6
|
1.0
|
CD1
|
B:LEU670
|
4.8
|
26.3
|
1.0
|
C8
|
B:0F4901
|
4.8
|
36.7
|
1.0
|
CG2
|
B:ILE600
|
5.0
|
32.5
|
1.0
|
CA
|
B:ILE695
|
5.0
|
27.0
|
1.0
|
O12
|
B:0F4901
|
5.0
|
36.4
|
1.0
|
|
Reference:
P.Albaugh,
Y.Fan,
Y.Mi,
F.Sun,
F.Adrian,
N.Li,
Y.Jia,
Y.Sarkisova,
A.Kreusch,
T.Hood,
M.Lu,
G.Liu,
S.Huang,
Z.Liu,
J.Loren,
T.Tuntland,
D.S.Karanewsky,
H.M.Seidel,
V.Molteni.
Discovery of Gnf-5837, A Selective Trk Inhibitor with Efficacy in Rodent Cancer Tumor Models. Acs Med Chem Lett V. 3 140 2012.
ISSN: ISSN 1948-5875
PubMed: 24900443
DOI: 10.1021/ML200261D
Page generated: Wed Jul 31 23:12:47 2024
|